Andreas Jurgeit

Andreas Jurgeit joined the Gimv Health & Care team in 2021.

Prior to that, he has been working at Lundbeckfonden Emerge (Copenhagen, DK) and at Merck Ventures (Amsterdam, NL) where he was responsible for VC investments and company creation in Europe, the US and Israel. Andreas started his career at Redalpine Venture Partners (Zurich, CH).

Andreas Jurgeit holds a PhD in Cell Biology/Virology from the University of Zurich (Switzerland) as well as a master’s degree in Molecular Biology from the University of Innsbruck (Austria).